Nanami Gotoh
Maebashi, 3718514, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Impact of inflammatory cytokine polymorphisms on the progression of myelodysplastic syndromes.
Journal: Annals of hematology
Published: June 11, 2025
Role of Rac1 in p53-Related Proliferation and Drug Sensitivity in Multiple Myeloma.
Journal: Cancers
Published: December 26, 2024
APEX1 Polymorphisms Affect Acute Myeloid Leukemia Risk, and Its Expression Is Involved in Cell Proliferation and Differentiation.
Journal: International journal of laboratory hematology
Published: May 23, 2024
Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.
Journal: International journal of molecular sciences
Published: December 16, 2022
Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar.
Journal: Acta haematologica
Published: October 11, 2022
Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression.
Journal: Clinical and experimental medicine
Published: September 13, 2022
MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression.
Journal: Genes
Published: August 05, 2022
Clinical significance of human endogenous retrovirus K (HERV-K) in multiple myeloma progression.
Journal: International journal of hematology
Published: December 07, 2021
IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma.
Journal: Clinical and experimental medicine
Published: November 18, 2020
DNA-double strand breaks enhance the expression of major histocompatibility complex class II through the ATM-NF-κΒ-IRF1-CIITA pathway.
Journal: Cancer gene therapy
Published: July 08, 2020
Last Updated: 09/26/2026